Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update

Cancer

Volumn 73, Issue 4, 1994, Pages 1134-1142

  Kemeny, Nancy ^a   Seiter, Karen ^a   Conti, John A ^a   Cohen, Alfred ^a   Bertino, Joseph R ^a   Sigurdson, Elin R ^a   Botet, Jose ^a   Chapman, Douglass ^a   Mazumdar, Madhu ^a   Budd, Andrew J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

colorectal neoplasms; floxuridine; hepatic arterial chemotherapy; hepatic neoplasms (secondary); leucovorin

Indexed keywords

FLOXURIDINE; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GASTROINTESTINAL TOXICITY; HEPATIC ARTERY; HEPATOBILIARY SYSTEM; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; METASTASIS; PRIORITY JOURNAL; SCLEROSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLOXURIDINE; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0027972450     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940215)73:4<1134::AID-CNCR2820730403>3.0.CO;2-V     Document Type: Article

References (34)

1. A chemotherapeutic approach to colorectal carcinoma
2. Treatment options for patients with metastatic colorectal cancer
3. Is hepatic infusion chemotherapy effective treatment for liver metastases? Yes
4. Cytotoxicity of 5‐fluorodeoxyuridine as well as 5‐fluorouracil cytotoxicity in human T‐lymphoblast leukemia cells: enhancement by leucovorin
5. Biochemical determinants of responsiveness to 5‐fluorouracil and its derivatives in xenografts of human colon adenocarcinomas in mice
6. Overview of clinical trials using 5‐FU and leucovorin for the treatment of colorectal cancer
7. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma
8. Clinical evaluation of chemotherapeutic agents in cancer
9. Prognostic variables in patients with hepatic metastases from colorectal cancer
10. The design and initial testing of an implantable infusion pump
11. Reporting results of cancer treatment
12. Non‐parametric estimation from incomplete observations
13. Evaluation of survival data and two new rank order statistics arising in its consideration
14. Clinical pharmacology of hepatic arterial chemotherapy
15. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries
16. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma
17. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial
18. Intra‐arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer
19. A prospective randomized trial of regional versus systemic continuous 5‐fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
20. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomized trial
21. Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT‐8) cells: relevance to cell growth inhibition
22. 5‐Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity
23. Mechanism of cytotoxicity of 5‐fluorouracil: distinction between the irreversible cytotoxic effect of 5‐fluorouridine and the reversible cytotoxic effect of 5‐fluoro‐2′‐deoxyuridine on murine lymphoma L5178Y cells in culture
24. Novel mechanism(s) of resistance to 5‐fluorouracil in human colon cancer (HCT‐8) sublines following exposure to two different clinically relevant dose schedules
25. Schedule‐dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid
26. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer
27. Intrahepatic arterial 5‐fluorouracil and folinic acid: clinical and pharmacokinetic evaluation [abstract]
28. Five years clinical experience with 5‐fluorouracil
29. Prognostic factors in advanced colorectal carcinoma
30. Design and conduct of clinical trials
31. Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer
32. Interferon alpha‐2a in 5‐fluorouracil for advanced colorectal carcinoma
33. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate